Rakuten Medical Advances Photo-Immunotherapy Cancer Treatment
INTERVIEW ON THE PRICE OF BUSINESS SHOW, MEDIA PARTNER OF THIS SITE.
Recently Kevin Price, Host of the nationally syndicated Price of Business Show, interviewed Abhijit Bhatia.
Abhijit Bhatia, Chief Operating Officer of Rakuten Medical, joined the Price of Business to discuss Rakuten Medical and its innovative Alluminox™ platform. Rakuten will develop a variety of precision, cell-targeting photoimmunotherapy treatments using the Alluminox platform for the treatment of cancer.
Rakuten Medical’s Alluminox technology consists of drug and device components and which Rakuten Medical hopes will become a potential 5th pillar of cancer treatment. The Alluminox™ platform has been shown in pre-clinical trials to target specific tumors as well as immunosuppressive cells for destruction with minimal effects on surrounding normal tissue. The first treatment under development on the Alluminox platform is ASP-1929 in combination with a targeted immunotherapy. Recently published clinical data have shown promose in the treatment of head & neck cancer.
ASP-1929 targeting EGFR is approved in Japan and has been marketed as Akalux® since January 2021 for unresectable locally advanced or recurrent head and neck cancer. ASP-1929 received Fast Track designation from the U.S. FDA in January 2018, and is currently under investigation in a global Phase 3 clinical trial for recurrent head and neck cancer but outside of Japan, ASP-1929 has not yet been approved by any regulatory authority.
For more information about Rakuten Medical and its ongoing clinical studies, please visit www.rakutem-med.com.
For more great lifestyle stories click here.
LISTEN TO THE INTERVIEW IN ITS ENTIRETY HERE:
The Price of Business is one of the longest running shows of its kind in the country and is in markets coast to coast. The Host, Kevin Price, is a multi-award winning author, broadcast journalist, and syndicated columnist. Learn more about the show and its digital partners at www.PriceofBusiness.com (scroll down to the bottom of the page).
